Advanced search
Publication Cover
Emerging Microbes & Infections Volume 10, 2021 - Issue 1
Submit an article Journal homepage
3,786
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination

Yuxin Chena Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Liguo Zhub Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of ChinaView further author information
,
Weijin Huangc Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institute for Food and Drug Control, Beijing, People’s Republic of ChinaView further author information
,
Xin Tongd Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Hai Wue Yurogen Biosystem LLC, Worcester, MA, USAView further author information
,
Yue Taoa Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaView further author information
,
Bei Tongf Institute of Botany, Jiangsu Province and Chinese Academy of Sciences, Nanjing, People’s Republic of ChinaView further author information
,
Haibin Huange Yurogen Biosystem LLC, Worcester, MA, USAView further author information
,
Jiachen Chene Yurogen Biosystem LLC, Worcester, MA, USAView further author information
,
Xiangan Zhaog Department of Gastroenterology, Northern Jiangsu People’s Hospital, Clinical Medical College of Yangzhou University, Yangzhou, People’s Republic of ChinaView further author information
,
Yang Loue Yurogen Biosystem LLC, Worcester, MA, USACorrespondence[email protected]
View further author information
&
Chao Wud Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1390-1403 | Received 02 Mar 2021, Accepted 06 Jun 2021, Published online: 08 Jul 2021

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Wanting Li, Tiantian Zhao, Bai Tao, Liwei Zhao, Hang Xiao, Xinyu Ding, Chuang Li, Lin Chen, Hao Cheng, Yang Lou, Yuxin Chen & Chao Wu. (2023) Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine. Human Vaccines & Immunotherapeutics 19:2.
Read now
Shengtao Fan, Kang Xiao, Dandan Li, Heng Zhao, Jingjing Zhang, Li Yu, Penglan Chang, Shuangli Zhu, Xingli Xu, Yun Liao, Tianjiao Ji, Guorun Jiang, Dongmei Yan, Fengyuan Zeng, Suqin Duan, Baicheng Xia, Lichun Wang, Fengmei Yang, Zhanlong He, Yang Song, Pingfang Cui, Xiaolei Li, Yaxing Zhang, Bangyi Zheng, Ying Zhang, Wenbo Xu & Qihan Li. (2022) Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants. Emerging Microbes & Infections 11:1, pages 212-226.
Read now
Jingjing Zhang, Han Zhang & Litao Sun. (2022) Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?. mAbs 14:1.
Read now
Nan-Chang Chiu, Hsin Chi, Yu-Kang Tu, Ya-Ning Huang, Yu-Lin Tai, Shun-Long Weng, Lung Chang, Daniel Tsung-Ning Huang, Fu-Yuan Huang & Chien-Yu Lin. (2021) To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination. Expert Review of Vaccines 20:10, pages 1211-1220.
Read now

Articles from other publishers (8)

Xiaoyu Chu, Xinyu Ding, Yixuan Yang, Yuchi Lu, Tinghan Li, Yan Gao, Le Zheng, Hang Xiao, Tingting Yang, Hao Cheng, Haibin Huang, Yang Liu, Yang Lou, Chao Wu, Yuxin Chen, Haitao Yang, Xiaoyun Ji & Hangtian Guo. (2023) Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2. Biochemical and Biophysical Research Communications 660, pages 43-49.
Crossref
Hangtian Guo, Yixuan Yang, Tiantian Zhao, Yuchi Lu, Yan Gao, Tinghan Li, Hang Xiao, Xiaoyu Chu, Le Zheng, Wanting Li, Hao Cheng, Haibin Huang, Yang Liu, Yang Lou, Henry C. Nguyen, Chao Wu, Yuxin Chen, Haitao Yang & Xiaoyun Ji. (2023) Mechanism of a rabbit monoclonal antibody broadly neutralizing SARS-CoV-2 variants. Communications Biology 6:1.
Crossref
Mingtao Liu, Hui Gan, Zhiman Liang, Li Liu, Qiwen Liu, Yiyin Mai, Huihuang Chen, Baoying Lei, Shangwei Yu, Huihui Chen, Peiyan Zheng & Baoqing Sun. (2023) Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies. Frontiers in Microbiology 14.
Crossref
Hernan H. M. da Costa, Diego J. B. Orts, Andrew D. Moura, Amaro N. Duarte-Neto, Cinthya S. Cirqueira, Rodrigo A. Réssio, Cristina T. Kanamura, Karen Miguita, Jerenice E. Ferreira, Raimunda T. M. Santos, Patricia P. Adriani, Jair P. Cunha-Junior, Renato M. Astray, Regina M. Catarino, Marcelo Lancelotti & Carlos R. Prudencio. (2023) RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2. Viruses 15:2, pages 555.
Crossref
Arnau Boix-Besora, Elianet Lorenzo, Jesús Lavado-García, Francesc Gòdia & Laura Cervera. (2022) Optimization, Production, Purification and Characterization of HIV-1 GAG-Based Virus-like Particles Functionalized with SARS-CoV-2. Vaccines 10:2, pages 250.
Crossref
Changchuin Mao, Richard Near, Xuemei Zhong & Wenda Gao. (2021) Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated IgG for enhanced ADCC. Antibody Therapeutics 4:3, pages 159-170.
Crossref
Yixin Liu, Xinsheng Zhou, Xuan Liu & Xiaotao Jiang. (2021) The immunology and immunotherapy for COVID-19. Expert Reviews in Molecular Medicine 23.
Crossref
Denis Jacob Machado, Richard Allen WhiteIIIIII, Janice Kofsky & Daniel A. Janies. (2021) Fundamentals of genomic epidemiology, lessons learned from the coronavirus disease 2019 (COVID-19) pandemic, and new directions. Antimicrobial Stewardship & Healthcare Epidemiology 1:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.